Cardiometabolic and Lipids Strategies for Primary Care-Cardiometabolic Effects of Fatty Kidney Disease

Video Transcription

Video Summary

Dr. Christian Mendy, a professor of medicine and nephrology at the University of California, San Diego, gave a lecture on the topic of fatty kidney disease. He discussed the relationship between obesity and kidney disease, focusing on the accumulation of fat in the kidneys. He highlighted the importance of recognizing fatty kidney disease as a separate clinical entity and integrating it into the spectrum of obesity-related diseases. Dr. Mendy explained the pathophysiology of fatty kidney disease, including the role of intracellular fat deposits and their impact on renal function. He discussed the epidemiology of the disease, noting that individuals with higher body mass indexes (BMI) are at an increased risk of developing chronic kidney disease (CKD) . He also highlighted the association between fatty kidney disease and hypertension, as well as its contribution to hyperglycemia in diabetes. Dr. Mendy emphasized the importance of weight loss in improving renal function and reducing albuminuria. He mentioned the potential benefits of certain medications, such as SGLT2 inhibitors, in treating fatty kidney disease. Lastly, he discussed the diagnostic challenges and the need for further research in this area. Overall, Dr. Mendy's lecture shed light on the relationship between obesity and kidney disease, specifically fatty kidney disease, and highlighted the importance of recognizing and addressing this condition. No credits were mentioned or granted in the transcript.

Keywords

fatty kidney disease

obesity

kidneys

renal function

chronic kidney disease

hypertension

hyperglycemia

weight loss

SGLT2 inhibitors